Vivos Therapeutics, Inc. (VVOS)
0.1489
0.00 (0.00%)
USD |
NASDAQ |
Oct 09, 16:00
0.1461
0.00 (0.00%)
After-Hours: 20:00
Vivos Therapeutics Enterprise Value : 13.83M for Oct. 9, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 13.83M |
| October 08, 2026 | 13.84M |
| October 07, 2026 | 13.86M |
| October 06, 2026 | 13.90M |
| October 05, 2026 | 13.90M |
| October 02, 2026 | 13.87M |
| October 01, 2026 | 13.83M |
| September 30, 2026 | 13.81M |
| September 29, 2026 | 13.85M |
| September 28, 2026 | 13.61M |
| September 25, 2026 | 13.71M |
| September 24, 2026 | 13.78M |
| September 23, 2026 | 13.83M |
| September 22, 2026 | 13.94M |
| September 21, 2026 | 13.99M |
| September 18, 2026 | 14.04M |
| September 17, 2026 | 14.22M |
| September 16, 2026 | 14.01M |
| September 15, 2026 | 14.04M |
| September 14, 2026 | 14.23M |
| September 11, 2026 | 14.34M |
| September 10, 2026 | 14.30M |
| September 09, 2026 | 14.14M |
| September 08, 2026 | 14.28M |
| September 04, 2026 | 14.37M |
| Date | Value |
|---|---|
| September 03, 2026 | 14.20M |
| September 02, 2026 | 14.17M |
| September 01, 2026 | 14.12M |
| August 31, 2026 | 14.51M |
| August 28, 2026 | 14.93M |
| August 27, 2026 | 15.42M |
| August 26, 2026 | 15.35M |
| August 25, 2026 | 15.52M |
| August 24, 2026 | 15.69M |
| August 21, 2026 | 15.98M |
| August 20, 2026 | 15.72M |
| August 19, 2026 | 15.67M |
| August 18, 2026 | 15.94M |
| August 17, 2026 | 16.04M |
| August 14, 2026 | 16.65M |
| August 13, 2026 | 16.10M |
| August 12, 2026 | 15.82M |
| August 11, 2026 | 16.24M |
| August 10, 2026 | 16.28M |
| August 07, 2026 | 16.37M |
| August 06, 2026 | 16.34M |
| August 05, 2026 | 16.61M |
| August 04, 2026 | 18.38M |
| August 03, 2026 | 17.78M |
| July 31, 2026 | 17.62M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Hinge Health, Inc. | 7.869B |
| Exlites Holdings International, Inc. | 19.82M |
| Xcelerate, Inc. | 10.42M |
| Pro-Dex, Inc. | 208.70M |
| Autonomix Medical, Inc. | -1.773M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.523M |
| Revenue (Quarterly) | 5.153M |
| Total Expenses (Quarterly) | 10.63M |
| EPS Diluted (Quarterly) | -0.31 |
| Gross Profit Margin (Quarterly) | 47.41% |
| Profit Margin (Quarterly) | -107.2% |
| Earnings Yield | -1.39K% |
| Normalized Earnings Yield | -1398.05 |